Kryptos Biotechnologies

Kryptos Biotechnologies, founded in 2017 by Jinyong Lee and Jun Ho Son, is a life science startup based in Hayward, California. The company's core mission is to illuminate the complexities of biology to improve patient lives and enhance the tools available to clinicians and scientists. Kryptos Biotechnologies offers innovative products such as an integrated sample-to-answer PCR molecular diagnostic system for point-of-care testing and precision medicine solutions focusing on single-cell analysis. Their market focus includes infectious disease diagnostics and personalized medicine.

Notable figures affiliated with Kryptos Biotechnologies include its founders, Jinyong Lee and Jun Ho Son, who bring significant expertise to the company. The startup has achieved key milestones in developing groundbreaking biotechnology that aids in the diagnosis and treatment of complex diseases. Their impact is evident in the improved diagnostic capabilities and personalized treatment options they provide, contributing significantly to advancements in the life sciences and healthcare sectors.